Dow Up 0.51% Nasdaq Up 0.24%

Novogen Limited (NVGN)

-NasdaqCM
1.80 Up 0.05(2.86%) Nov 21, 3:58PM EST
Prev Close:1.75
Open:1.82
Bid:N/A
Ask:2.01 x 100
1y Target Est:N/A
Beta:-1.09
Next Earnings Date:N/A
Day's Range:1.78 - 1.94
52wk Range:1.51 - 6.54
Volume:27,503
Avg Vol (3m):19,922
Market Cap:12.14M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback